Myeloma overexpressed (MYEOV) acted as an amplified competing endogenous RNA in promoting metastasis by activating TGF-β pathway in non-small cell lung cancer and served as the potential therapeutic target (Fang et al., 2019). The gene discussed is TGFB1; the disease is plasma cell myeloma.